Effect of Clonidine Additive to suprascapular_ Costoclavicular Versus Standard Interscalene Block in Arthroscopic Shoulder Surgeries
NCT ID: NCT07256938
Last Updated: 2025-12-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
PHASE4
60 participants
INTERVENTIONAL
2025-12-31
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Recently, clinicians have explored new ways to provide satisfactory analgesia while minimizing the pulmonary side effects of the interscalene nerve block. One of these solutions might be to offer the patient a suprascapular nerve block combined to costoclavicular block. Since these blocks are performed lower in the neck or under the clavicle, the phrenic nerve is less likely to be blocked. Thus, fewer respiratory side effects have been reported when using such blocks.
Hypothesis The main hypothesis of this study is that the addition of clonidine to suprascapular block combined with costoclavicular block is not inferior to the standard interscalene brachial plexus block in terms of postoperative analgesia. We postulate that pain score postoperatively and opioid requirements will not differ significantly in patients who receive either block.
Our secondary objectives will consist in looking at the differences in intraoperative , arm motor block , diaphragmatic paresis , patient satisfaction and time for readiness to discharge from PACU .we hypothesize that these outcomes will be similar in both groups , with the exception of a potential reduction in arm motor block and diaphragmatic paresis in the combined suprascapular and costoclavicular block group The primary objective of this study will be to evaluate the postoperative pain score during arthroscopic shoulder surgery assessed by the pain score when comparing the effect of addition of clonidine to suprascapular\_costoclavicular versus standard interscalene
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison Between Interscalene and Combined Costoclavicular-suprascapular Blocks for Arthroscopic Shoulder Surgery
NCT04224766
The Effects of Different Clonidine Concentrations on Axillary Brachial Plexus Block With 1,5% Lidocaine
NCT01620112
A Comparison of Ropivacaine Alone Versus Combination of Dexamethasone and Clonidine for Block
NCT02151487
Anterior Suprascapular Nerve Block is an Effective and Diaphragm Protective Approach for Arthroscopic Shoulder Surgery
NCT04626869
Pulmonary Function and Interscalene Block
NCT02181296
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
US-guided costoclavicular block
Bupivacaine 0.5% (hyperbaric)
5 mL bupivacaine 0.5%,
US-guided costoclavicular block
US-guided costoclavicular block
Interscalene brachial plexus block
single shot US-guided interscalene brachial plexus block
clonidine 1 mg / kg
clonidine 1 mg / kg
Group B
US-guided interscalene brachial plexus block
Bupivacaine 0.5% (hyperbaric)
5 mL bupivacaine 0.5%,
US-guided costoclavicular block
US-guided costoclavicular block
clonidine 1 mg / kg
clonidine 1 mg / kg
single shot US-guided suprascapular nerve block
single shot US-guided suprascapular nerve block
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bupivacaine 0.5% (hyperbaric)
5 mL bupivacaine 0.5%,
US-guided costoclavicular block
US-guided costoclavicular block
Interscalene brachial plexus block
single shot US-guided interscalene brachial plexus block
clonidine 1 mg / kg
clonidine 1 mg / kg
single shot US-guided suprascapular nerve block
single shot US-guided suprascapular nerve block
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Omar Fathy Khedr
residant doctor at Assiut university hospital
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
clonidine + suprascapular
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.